Actualités sur Medizin, Gesundheit

Poda Lifestyle and Wellness Ltd.

Poda's Chief Medical Officer Commences Clinical Trial

Vancouver, Bc (ots/PRNewswire) - PODA LIFESTYLE AND WELLNESS LTD. ("Poda" or the "Company") (CSE: PODA) (FSE: 99L) (OTC PINK: PODAF) is pleased to announce that Dr. Jagdeep Gupta, MD ("Dr. Gupta"), Chief Medical Officer of the Company, has commenced setting up the first clinical trials for Poda's smoking cessation products. Dr. Gupta commented, "I have already initiated the process of setting up the first clinical trials ...

CartiHeal (2009) Ltd.

CartiHeal Announces Pivotal Study Results Demonstrate Agili-C(TM) Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects

Kfar Saba, Israel (ots/PRNewswire) - According to a Two-Year Randomized and Controlled Multinational IDE Study CartiHeal Ltd, developer of Agili-C(TM), a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, which was granted Breakthrough Device Designation by the FDA last ...

GES

GES Acquires Aqwise in a Strategic Move to Form a Leading Global Water & Wastewater Treatment Technology Group

Tel Aviv, Israel (ots/PRNewswire) - GES CEO, Michael Dayan, explained that the Aqwise acquisition positions GES as a leading, dominant player in the Water, Industrial & Municipal Wastewater Market in Israel and worldwide GES, which operates in the desalination, water treatment and wastewater sector announced today ...

swissstaffing - Verband der Personaldienstleister der Schweiz

Swiss Staffingindex - Strong Recovery in the Staff Leasing Sector: Working Hours up Almost 25% This Quarter Year-on-Year

RadiAction Medical Ltd.

The new patents highlight Radiaction's superior innovation in radiation protection

Tel Aviv, Israel (ots/PRNewswire) - Radiaction Medical Ltd. ("Radication"), a medical device company, announced today that it was granted additional patents in the US and Japan, protecting key technological developments of its radiation shielding device. Radiaction, is revolutionizing radiation protection by providing full-body shielding to all medical personnel during ...

Norgine; US WorldMeds

Norgine B.V. and US WorldMeds enter into exclusive licensing agreement to commercialise DFMO (eflornithine) in Europe, Commonwealth of Independent States, Australia and New Zealand

Amsterdam, Netherlands and Louisville, Ky. (ots/PRNewswire) - NORGINE B.V. (Norgine) a leading European specialist pharmaceutical company and US WorldMeds (USWM), a Kentucky-based specialty pharmaceutical company, today announced an exclusive licensing agreement by which Norgine will register and commercialise ...

Poda Lifestyle and Wellness Ltd.

Poda CEO Provides Update on Heated Tobacco Market

Vancouver, Bc (ots/PRNewswire) - PODA LIFESTYLE AND WELLNESS LTD. ("Poda" or the "Company") (CSE: PODA) (FSE: 99L) (OTCPINK: PODAF) is pleased to provide an update from CEO Ryan Selby on the state of the global heated tobacco market. Ryan Selby, CEO, commented, "With an ever-increasing focus on reduced-risk products, the global tobacco industry continues to embrace heated tobacco products. International tobacco giant ...

Poda Lifestyle and Wellness Ltd.

Poda Enters Medical Device Market and Hires Chief Medical Officer

Vancouver, Bc (ots/PRNewswire) - PODA LIFESTYLE AND WELLNESS LTD. ("Poda" or the "Company") (CSE: PODA) (FSE: 99L) (OTC PINK: PODAF) is pleased to announce that it has appointed Dr. Jagdeep Gupta, MD ("Dr. Gupta") as Chief Medical Officer of the Company. Ryan Selby, CEO, commented, "I am very pleased to have received approval from the Board to enter the medical device market and to create the position of Chief Medical ...

News Direct

Leaders in built-in antimicrobial technology become a united powerhouse

North Carolina, USA (ots) - --News Direct-- Microban® International is proud to announce that it is bringing together its Microban® and Ultra-Fresh® brands and technologies under a single umbrella. Following the initial acquisition of Thomson Research Associates in 2016, Microban International will now completely harmonize the two organizations, as these titans ...

Schweizerischer Nationalfonds / Fonds national suisse

Cancerous tumours: how likely are they to metastasise?

Bern (ots) - A very aggressive type of cancer has provided a team of researchers supported by the Swiss National Science Foundation with an answer to the question of which tumour cells are at risk of spreading. Cancer treatment is sometimes complicated by the heterogeneity of the cells that form the tumour mass. The problem is how to identify the few cells that are capable of triggering metastases. Thanks to work carried ...

The Untold Story

The Untold Story Releases Zhang Boli's Short Documentary on the Battle Against the Pandemic

News Direct

ZOE Study Reveals Eating a Plant Rich Diet Reduces Risk of Developing COVID-19 and Going to the Hospital

Abcam plc

Abcam opens new US facility in Boston, MA

Cambridge (ots/PRNewswire) - Supporting accelerated growth of R&D, manufacturing, and commercial activities with new 100,000 sq-ft state-of-the-art facility Reinforcing commitment to the region as Abcam approaches 20 years of US presence Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in Waltham, MA. The new facility is a central ...

Schweizerischer Nationalfonds / Fonds national suisse

Clinical research: patients and the public have their say

Bern (ots) - The Swiss National Science Foundation has been funding clinical studies on under-researched topics in medicine since 2016. In a first, it successfully involved representatives of patients and the public in evaluating applications. The aim of the SNSF's Investigator Initiated Clinical Trials (IICT) programme is to answer medical questions that are important to society but not a priority for industry. This ...

Servier; Nymirum

Servier and Nymirum Announce Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics

Paris (ots/PRNewswire) - Servier, a global independent pharmaceutical Group, and Nymirum, a pioneer in RNA-targeted small molecules, announced today that they have entered into a strategic collaboration to identify and develop RNA-modulatory drugs for the treatment of neurological diseases. Under the collaboration ...

GSK Consumer Healthcare

COVID pandemic heightens a lack of confidence amongst the public about which medicines to take and how to use them

Nyon, Switzerland (ots/PRNewswire) - New campaign, Let's treat it right, launches as online searches for self-care surge globally[1], as people take more responsibility for their everyday health. Today sees the launch of Let's treat it right, a major new health education campaign designed to bridge a knowledge gap ...

GSMA

GSMA Celebrates The Return Of MWC Barcelona

Barcelona, Spain (ots/PRNewswire) - Getting back to business and back together to discuss Connected Impact at the historic hybrid event The GSMA is celebrating the safe and successful return of MWC Barcelona, the world's largest mobile ecosystem event. It is humbling that in the most challenging circumstances, people came together for MWC21. Convening this year was possible because of a commitment to innovation and the ...

Poda Lifestyle and Wellness Ltd.

Former JUUL Head of Corporate Affairs Joins Poda Team

Vancouver, Bc (ots/PRNewswire) - PODA LIFESTYLE AND WELLNESS LTD. ("Poda" or the "Company") (CSE: PODA) (FSE: 99L) (OTC PINK: PODAF)is pleased to announce that former Head of Corporate Affairs for JUUL Labs Inc. Nicholas Kaydsh has joined Poda as a member of the Global Advisory Board. With over a decade of experience as a public affairs and regulatory expert, Mr. Nicholas ("Nick") Kaydsh has led government relations and ...

Almirall; MC2 Therapeutics

Almirall and MC2 Therapeutics announce completion of decentralized procedure in Europe for the topical treatment of mild to moderate psoriasis vulgaris in adults

Barcelona, Spain and Copenhagen, Denmark (ots/PRNewswire) - - The successful completion of a decentralized procedure is the final step before national marketing authorizations can be granted by the European countries - MC2 Therapeutics has granted Almirall exclusive European rights to commercialize this topical ...

Tianjin Haihe Media Group

Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM

Wuhan (ots) - In September, 2020, Zhang Boli was awarded with the national honorary title, "the People's Hero," for his outstanding contribution to the country's fight against the COVID-19 pandemic. The decision was made to commend people who have made outstanding contribution in the fight, and carry forward their dedication and other noble qualities. This short ...

Tianjin Haihe Media Group

Tianjin Haihe Media Group presents the story of Zhang Boli in fighting COVID-19 with TCM

Tianjin, China (ots) - In September, 2020, Zhang Boli was awarded with the national honorary title, "the People's Hero," for his outstanding contribution to the country's fight against the COVID-19 pandemic. The decision was made to commend people who have made outstanding contribution in the fight, and carry forward their dedication and other noble qualities. This ...

News Direct

3

Vascudyne Announces Successful First Human Use of TRUE Vascular Graft for Hemodialysis Access

Pierre Fabre; EORTC

European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients

Brussels and Castres, France (ots/PRNewswire) - Partnership builds on complementary strengths to advance research in melanoma with a focus on Stage 2 melanoma patients European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre today announced a strategic partnership in support of patients ...

Poda Lifestyle and Wellness Ltd.

Former JUUL President Joins Poda Team

Vancouver, Bc (ots/PRNewswire) - PODA LIFESTYLE AND WELLNESS LTD. ("Poda" or the "Company") (CSE: PODA) (FSE: 99L) (OTC PINK: PODAF)is pleased to announce that former JUUL Canada President Michael Nederhoff has joined Poda as a member of the Global Advisory Board and consultant to Poda's management team and the Company's Board. As part of the consulting agreement, Mr. Nederhoff will be assisting Poda with its global ...

Abcam; Pionyr

Pionyr and Abcam extend partnership to evaluate TREM2-expressing cells in cancer patients

South San Francisco, Calif. and Cambridge, England (ots/PRNewswire) - - The partnership will support the progression of PY314, the first of Pionyr's Myeloid Tuning(TM) antibodies to enter the clinic - Pionyr will use Abcam's EPR20243 clone to evaluate TREM2 levels in tissue samples for potential future development ...

Valcon Medical A/S

Valcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations

Copenhagen (ots/PRNewswire) - Valcon Medical A/S ("Valcon Medical" or the "Company"), Denmark's leading independent cannabis concentrate and medical formulation provider, received its licensing for the commercial production of cannabis from the Danish Medicines Agency (DKMA) earlier in May 2021. Under the DKMA ...

Epredia

Epredia And Aiforia Announce Partnership For Global Distribution Of AI-powered Pathology Software

Portsmouth, N.h. (ots/PRNewswire) - Epredia, a global leader in precision cancer diagnostics, and Aiforia, a medical software company providing Artificial Intelligence (AI) based solutions for image analysis in pathology, have announced today that they have entered into a commercial distribution agreement for ...

Norgine

Norgine B.V. enters into exclusive distribution agreement for the commercialisation of PLENVU® in China with Beijing Podconley Pharmaceutical Technology & Development Co., Ltd.

Amsterdam (ots/PRNewswire) - NORGINE B.V. (Norgine) a leading European specialist pharmaceutical company and Beijing Podconley Pharmaceutical Technology & Development Co., Ltd. (Beijing Podconley), today announced an exclusive distribution agreement by which Beijing Podconley will commercialise Norgine's product ...

Debiopharm International SA

DEBIOPHARM AND UBIX THERAPEUTICS LAUNCH RESEARCH TO DEVELOP A NEW ANTI-CANCER MODALITY - ANTIBODY DEGRADUCER® CONJUGATES

Lausanne, Switzerland, Seoul, Republic of Korea (ots) - Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company and Ubix Therapeutics (en.ubixtrx.com), a South Korea-based biotech company today announced their co-research agreement combining two novel proprietary technologies to specifically ...

Planetwatch sas

PlanetWatch, a decentralized environmental monitoring pioneer, announces a major transatlantic partnership

Saint-Genis-Pouilly, France (ots/PRNewswire) - PlanetWatch, a French company which decentralizes and incentivizes environmental monitoring by leveraging the Algorand blockchain, is announcing a strategic partnership with EMRIT, a US-based company which is building the new IoT wireless internet. EMRIT will fund the ...